QIETIFY
Live / Applied — Fourth extension granted (statement of use) (as of 23 Dec 2025)
What this means for you
Not registered yet, but its 20 Dec 2022 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97725844
- Mark type
- Stylized text
- Filed
- 20 Dec 2022
- Published for opposition
- 31 Oct 2023
- Attorney of record
- Sarah Anne Keefe
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of human and veterinary diseases and disorders, namely, addiction, autism, auditory diseases and disorders, autoimmune diseases and disorders, anxiety, bone diseases and disorders, cardiovascular diseases and disorders, cardiopulmonary diseases and disorders, central nervous system diseases and disorders, cognitive diseases and disorders, dermatological diseases and disorders, diabetic diseases and disorders, endocrine diseases and disorders, fragile x syndrome, gastroenterological diseases and disorders, genetic diseases and disorders, genitourinary diseases and disorders, hepatological diseases and disorders, hormonal diseases and disorders, infectious diseases and disorders, immunological diseases and disorders, inflammatory diseases and disorders, metabolic diseases and disorders, movement diseases and disorders, muscular diseases and disorders, musculoskeletal diseases and disorders, neurodegenerative diseases and disorders, neurological diseases and disorders, oncological diseases and disorders, ophthalmic diseases and disorders, pain, post-traumatic stress, pulmonary diseases and disorders, renal diseases and disorders, respiratory diseases and disorders, rheumatological diseases and disorders, psychiatric diseases and disorders, seizure diseases and disorders, sexual dysfunction, speech diseases and disorders, and viral diseases and disorders
Owner
- Zynerba Pharmaceuticals, Inc., Devon, PA, US
- Zynerba Pharmaceuticals, Inc., Devon, PA, US
Prosecution history
- 24 Dec 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 23 Dec 2025 — SOU EXTENSION 4 GRANTED
- 23 Dec 2025 — SOU EXTENSION 4 FILED
- 23 Dec 2025 — SOU TEAS EXTENSION RECEIVED
- 24 Jun 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 23 Jun 2025 — SOU EXTENSION 3 GRANTED
- 23 Jun 2025 — SOU EXTENSION 3 FILED
- 23 Jun 2025 — SOU TEAS EXTENSION RECEIVED
- 25 Oct 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 25 Oct 2024 — SOU EXTENSION 2 GRANTED
- 25 Oct 2024 — SOU EXTENSION 2 FILED
- 25 Oct 2024 — SOU TEAS EXTENSION RECEIVED
- 24 May 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 23 May 2024 — SOU EXTENSION 1 GRANTED
- 23 May 2024 — SOU EXTENSION 1 FILED